UBS analyst Timothy Chiodo downgraded Nuvei to Neutral from Buy with a price target of $34, up from $30, after the company entered into an agreement to be taken private by Advent international for $34 per share in an all-cash transaction. The firm expects the deal to close by late 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
